Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ripasudil (K-321) Eye Drops After Cataract Surgery
NCT05528172Phase 3Completed
- Start
- Aug 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ripasudil in corneal edema. Started Aug 2022; status: completed.
02
Drugs
ripasudil
03
Conditions
corneal edema
Beyond the preview
Go deeper on NCT05528172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05528172.